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Abstract
Background. Anxiety disorders are highly prevalent with an early age of onset.
Understanding the aetiology of disorder emergence and recovery is important for establishing
preventative measures and optimising treatment. Experimental approaches can serve as a use-
ful model for disorder and recovery relevant processes. One such model is fear conditioning.
We conducted a remote fear conditioning paradigm in monozygotic and dizygotic twins to
determine the degree and extent of overlap between genetic and environmental influences
on fear acquisition and extinction.
Methods. In total, 1937 twins aged 22–25 years, including 538 complete pairs from the Twins
Early Development Study took part in a fear conditioning experiment delivered remotely via
the Fear Learning and Anxiety Response (FLARe) smartphone app. In the fear acquisition
phase, participants were exposed to two neutral shape stimuli, one of which was repeatedly
paired with a loud aversive noise, while the other was never paired with anything aversive.
In the extinction phase, the shapes were repeatedly presented again, this time without the
aversive noise. Outcomes were participant ratings of how much they expected the aversive
noise to occur when they saw either shape, throughout each phase.
Results. Twin analyses indicated a significant contribution of genetic effects to the initial
acquisition and consolidation of fear, and the extinction of fear (15, 30 and 15%, respectively)
with the remainder of variance due to the non-shared environment. Multivariate analyses
revealed that the development of fear and fear extinction show moderate genetic overlap (gen-
etic correlations 0.4–0.5).
Conclusions. Fear acquisition and extinction are heritable, and share some, but not all of the
same genetic influences.
Introduction
Anxiety disorders affect over 20% of individuals during their lifetime (Kessler et al., 2012),
have an early age of onset (Kessler et al., 2005) and are currently increasing sharply in preva-
lence (Baker, 2020; O’Connor, Downs, Shetty, & McNicholas, 2020). Both genetic and envir-
onmental influences are implicated in the development of anxiety, with twin heritability
estimates ranging from 20% to 60% (Ask, Torgersen, Seglem, & Waaktaar, 2014; Meier
et al., 2019; Polderman et al., 2015), and estimates of heritability derived from genome-wide
association studies (GWASs) ranging from 1.7% in childhood and adolescence to 31% in
adulthood (for a review see Ask et al., 2021). Notably, the upper range of heritability estimated
from common genetic variants indexed by genome-wide analyses of anxiety [single-nucleotide
polymorphism (SNP) heritability] overlaps with the lower end of estimates from twin studies.
This is unusual, with SNP heritability substantially less than half that of twin heritability
observed for most psychiatric disorders (Yang, Zeng, Goddard, Wray, & Visscher, 2017).
This might suggest a larger role for common genetic variants in anxiety in particular.
Effectively, evidence-based treatments exist for anxiety disorders, notably pharmacological
approaches such as antidepressants and benzodiazepines (Baldwin et al., 2014), and psycho-
logical approaches such as cognitive behavioural therapy (CBT) (Carpenter et al., 2018;
Hofmann & Smits, 2008). However, only ∼50% of individuals respond regardless of treatment
type (Clark et al., 2009; Cuijpers, Cristea, Karyotaki, Reijnders, & Huibers, 2016; Loerinc et al.,
2015; Rush et al., 2006). Individual differences in treatment response are likely to be heritable,
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given known genetic influences on response to many aspects of the
environment, such as life events and parenting (Kendler & Baker,
2007). Although there is evidence for familial clustering
(Franchini, Serretti, Gasperini, & Smeraldi, 1998; O’Reilly, Bogue,
& Singh, 1994) and influence of common genetic variants (Tansey
et al., 2013) in response to antidepressant treatment for depression,
the heritability of psychological treatment response is currently
unknown. The largest studies in this field to date, both of which
are genome-wide analyses, were insufficiently powered to draw
strong conclusions (Coleman et al., 2016; Rayner et al., 2019).
Crucially, we do not yet know the specific mechanisms
through which anxiety develops or recovery occurs, or how gen-
etic influences contribute to these. Furthermore, using an experi-
mental model of specific processes underlying disordered anxiety
and treatment response has the advantage of a likely reduction in
heterogeneity in the dataset (Scheveneels, Boddez, Vervliet, &
Hermans, 2016). One possible set of experimental mechanisms
is the acquisition and subsequent extinction of fears through dir-
ect learning experiences. These processes can be measured using
fear conditioning paradigms. During the fear acquisition phase,
participants are exposed to two neutral stimuli, known as condi-
tional stimuli (CS), one of which is repeatedly paired with an
aversive (e.g. a loud noise) or unconditional stimulus (US). The
stimulus paired with the US is referred to as the CS+. The
other stimulus is never paired with anything aversive and is
referred to as the CS−. Over repeated trials, participants learn
that the CS+ is associated with the aversive stimulus and typically
demonstrate a ‘fear’ or ‘anxiety’ response to the CS+. This initial
phase models processes implicated in anxiety development.
Following acquisition, participants undergo an extinction phase
where both CS+ and CS− are repeatedly presented without the
aversive noise. The extinction phase models exposure-based treat-
ment of fear and anxiety disorders used in CBT (Hofmann, 2008),
which developed out of the fear extinction literature (Eelen &
Vervliet, 2006).
A common way of measuring conditioning is to require parti-
cipants to rate how much they expected the aversive outcome to
occur with the CS+ and CS− throughout the task (Lonsdorf
et al., 2017). These assessments can be thought of as risk-
estimates. In order to measure task-related learning while control-
ling for general interindividual differences in responsivity, a
differential metric (risk-estimates for the CS− subtracted from
the risk-estimates for the CS+) is often calculated (Lonsdorf
et al., 2017). In order to investigate the underlying contributions
of genes and environment to these mechanisms, sample sizes are
needed far in excess of those typically included in laboratory
administered studies of fear conditioning. Notably, only one
study in the largest meta-analysis of fear conditioning to date con-
tained over 100 participants (Duits et al., 2015). One prior twin
study obtained preliminary estimates of heritability of skin conduct-
ance responses during fear acquisition and extinction (0.20–0.46),
and genetic overlap between them (Hettema, Annas, Neale,
Kendler, & Fredrikson, 2003). However, although large in terms
of fear conditioning, the sample size (173 twin pairs) was small
for genetic analyses, as evidenced by large confidence intervals
(CIs). Furthermore, the sample was split into two groups, each of
which received a different stimuli set. Thus, although this provides
preliminary evidence for the heritability of fear acquisition, extinc-
tion and their overlap, a larger, more heterogeneously administered
study is required to consider this question.
The current study aimed to answer two important questions:
(1) to what extent are fear acquisition and extinction influenced
by genetic and environmental factors; and (2) are the genetic
and environmental influences on the acquisition and extinction
of fear shared between all processes, or are there distinct influ-
ences on each phase? We used the recently developed Fear
Learning and Anxiety Response (FLARe) smartphone app
(Purves et al., 2019) to remotely administer a differential fear con-
ditioning and extinction paradigm to a subset of twins from the
Twins Early Development Study (TEDS) (Rimfeld et al., 2019).
We assessed participant discrimination between the CS+ and
CS− during early and late acquisition and extinction.
Methods
Sample
Participants were recruited by email invitation sent to 5934 twins
enrolled in the TEDS (Rimfeld et al., 2019), a longitudinal birth
cohort study of twins born in England and Wales between 1994
and 1996. Twins who agreed downloaded the FLARe app
(Purves et al., 2019) via the iTunes or Google Play Stores. The
experiment was completed by 2554 individuals of whom 1937
were included in the analyses after excluding those who removed
their headphones, reduced phone volume <50% or exited the app
during the task. See Online Supplementary Fig. S1 for a detailed
illustration of participant drop-out at each stage. We explored the
characteristics of twins who chose to participate in the study (n =
2554) compared to those who did not (n = 3380). Our participant
groups were more likely to be older [d = 0.07; t(5909.9) = 2.78, p =
0.006], female (odds ratio 1.67; 95% CI 1.50–1.86, p < 0.001) and
to have lower socioeconomic status (d = 0.08; U = 866 163, p =
0.036) than those who chose not to take part. However, there
were no statistically significant differences in anxiety scores
between respondents and non-respondents (d = 0.05; U = 1 065
914.5, p = 0.191).
Twin zygosity was determined by parental responses to a twin
similarity questionnaire. This has 95% concordance with geno-
typed zygosity (Price et al., 2000). The sample consisted of 250
complete monozygotic pairs (MZF = 180, MZM = 70), 288 dizyg-
otic pairs (DZF = 131, DZM = 50, DZopp = 107) and 860 single-
tons (F = 549, M = 312). See Online Supplementary Table S1 for
a description of the total sample including age, gender and self-
reported clinician-provided diagnoses of any anxiety or depressive
disorder.
Experimental procedure
Participants were given instructions designed to maintain optimal
experimental conditions, ensure headphone usage and maximum
phone volume (see online Supplementary Figs S2 and S3). They
were asked to complete the task in a single, undisturbed session.
The fear conditioning procedure began with a fear acquisition
phase during which 12 presentations each of a large and small cir-
cle (CS) were shown in a pseudo-randomised sequence on a back-
ground image of an outdoor scene. One of these (CS+) was paired
with the aversive ‘unconditional stimulus’ (US; a loud scream
sound) during the final 500 ms of the trial on nine out of 12 pre-
sentations (75% reinforcement). The other was never paired with
the US (CS−). The use of the large v. small circle as the CS+ was
counterbalanced across participants. See online Supplementary
material for trial presentation rules. Participants then had a
break of at least 10-min, during which they were unable to con-
tinue with the task due to a built-in time-based restriction within
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the app and completed a series of online questionnaires. This was
followed by a fear extinction phase. This break was enforced in
order to ensure a clear temporal distinction between the acquisi-
tion and extinction phases. The same large and small circles were
shown 18-times each on the background of an indoor living room
scene. Neither shape was paired with the aversive stimulus. We
used 18 trials in the extinction phase to ensure full extinction
prior to the end of the task, given the remote delivery. After the
extinction phase, participants were redirected to an external web-
site (Qualtrics, 2019) to answer questions including whether or
not they removed their headphones during the task. See Fig. 1
for a schematic diagram of the experimental procedure.
Fig. 1. Schematic diagram of fear conditioning procedures as implemented in the FLARe app. This figure shows trial and overall task structure of the fear con-
ditioning task as implemented in the Fear Learning and Anxiety Response (FLARe) app. CS: conditional stimuli. Context: background image of an outdoor garden
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Outcome measures
During each trial, participants were asked to rate how much they
expected to hear the aversive stimulus on a scale ranging from 1
(completely certain NO scream will occur) to 9 (completely cer-
tain a scream WILL occur). Risk-estimates (sometimes known
as expectancy ratings) for the CS− were subtracted from those
of the CS+ to obtain differential scores, an index of how well par-
ticipants were able to differentiate between the two experimental
cues. Repetition is a core component of memory and learning
(Hintzman, 1976), and evidence from neuroimaging paradigms
demonstrates that the association between fear conditioning and
brain regions varies across time within phase (LaBar, Gatenby,
Gore, LeDoux, & Phelps, 1998). Thus, in order to assess rapid
acquisition of fear learning relative to later, consolidated fear
learning after several repetitions, the post hoc decision was
taken to consider fear acquisition and extinction in early and
late stages. Differential scores created from risk-estimates made
during the first and final thirds of the acquisition phase and the
first third of the extinction phase were retained to assess the initial
development, consolidation and extinction of fear learning
respectively (see Fig. 2). Differential scores for the last third of
the extinction trials (late extinction) were not analysed in twin
modelling as by this stage nearly all participants had reduced
their risk-estimates for both stimuli to ∼1 (see Table 1).
Statistical analyses
Data preparation
Outcome variables (initial development, consolidation and fear
extinction) were age and sex regressed to avoid artificial inflation
of twin correlations (McGue & Bouchard, 1984), and the residuals
were normalised using square-root transformation in R.
Multivariate twin modelling
Monozygotic (MZ) twins share 100% of their segregating genes,
dizygotic (DZ) twins share ∼50%, while both MZ and DZ twins
share their rearing environments (Rijsdijk & Sham, 2002).
Monozygotic and dizygotic twin similarity can be compared to
estimate genetic and environmental influences on a trait. The
degree to which MZ twins are more similar than DZ twins reflects
approximately half (100–50%) of the genetic influence (labelled
A; additive genetic influence). Twin resemblance not due to gen-
etic factors is attributed to environmental factors that make twins
more similar (common environmental factors, labelled C).
Finally, the extent to which the MZ twin correlation differs
from 1 reflects the non-shared environment and residual/error
variance (labelled E).
A trivariate correlated factors solution of the Cholesky decom-
position model was applied (see Fig. 3). This estimates the relative
influence of latent factors A, C and E on each of the fear condi-
tioning variables as well as the correlations between the genetic
and environmental influences on each (Loehlin, 1996). These
parameters are then used to estimate the degree to which pheno-
typic correlations are attributable to genetic and environmental
influences.
Genetic modelling was undertaken in R using the OpenMx
package (Boker et al., 2011). OpenMx used full information max-
imum likelihood to estimate structural equation parameters, an
effective method to deal with missing data (Boker et al., 2016;
Jelicić, Phelps, & Lerner, 2009). Model fit was assessed using χ2
and Akaike’s information criterion.
Results
Differential fear conditioning
As shown in Fig. 2, the difference between the CS+ and CS− was
largest during the last four trials of acquisition, the phase we refer
to as consolidation. The difference was smallest during late fear
extinction when reinforcement of either stimulus had ceased.
During the first four trials of acquisition (initial development),
participants already showed a greater expectation of the
scream occurring to the CS+ than the CS−, see first row, first sec-
tion of Table 1 (meanCS+ = 6.05, S.D.CS+ = 1.63, meanCS− = 3.70,
S.D.CS− = 1.56). By the consolidation phase (second row),
risk-estimates had further increased for the CS+ and decreased
for the CS−. Average risk-estimates reduced for both stimuli
over the course of extinction. During the first third of extinction
trials, ratings were similar to average risk estimates during the
initial development of fear. By the end of extinction, almost all
participants had ceased to report any expectation of a scream
occurring for either stimulus.
Trivariate twin modelling
See Table 1 middle section for monozygotic and dizygotic twin
correlations for each fear conditioning variable and Table 2 for
Fig. 2. Average risk-estimates per trial across all participants
during fear conditioning task. Average risk-estimate per
stimulus, per trial, averaged across all participants. Dashed
lines indicate standard error of the mean (note, these inter-
vals are narrow). CS+, conditional stimulus paired with the
aversive scream; CS−, conditional stimulus never paired
with the aversive scream.
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cross-twin cross-trait genetic and phenotypic correlations. We
only report results from multivariate modelling, as these are better
powered compared to univariate models. The ACE model pro-
duced C estimates that were zero and non-significant (see online
Supplementary Fig. S4), and we therefore tested a more parsimo-
nious AE model. This did not result in loss of fit and was there-
fore selected as the final model (see online Supplementary
Table S2 for model fit information).
Table 2. Cross-twin cross-trait (lower) and phenotypic (upper) correlations with proportion of variance explained by A and E
Initial development Consolidation Extinction
Initial development 0.32 (0.08–0.25) 0.59 (0.55–0.64)
A 37% | 63% E
0.32 (0.28–0.38)
A 19% | 81% E
Consolidation 0.21 (0.13–0.29)
0.12 (0.05–0.20)
0.29 (0.18–0.39) 0.38 (0.34–0.43)
A 22% | 78% E
Extinction 0.05 (−0.05 to 0.15)
0.04 (−0.05 to 0.15)
0.08 (0.00–0.17)
0.03 (−0.04 to 0.13)
0.15 (0.04–0.25)
This table shows cross-twin cross-trait correlations (95% CI) for MZ (top) and DZ (bottom) twin pairs (below diagonal) and phenotypic correlations (95% CI) with the standardised proportion
of phenotypic association accounted for by A/E (above diagonal). Estimate of heritability from multivariate twin analyses (95% CI) shown on the diagonal. CIs are obtained by bootstrapping
over 100 iterations.
Fig. 3. Trivariate-correlated factors solution showing
genetic and environmental influences on the initial
development, consolidation and extinction of fear con-
ditioning. This figure shows the standardised path esti-
mates and 95% CIs for the AE trivariate-correlated
factors solution of the Cholesky model. A, additive gen-
etic effects; E, non-shared environment effects. Note
that A and E present the proportion of phenotypic vari-
ance in each outcome accounted for by additive genetic
and non-shared environment effects respectively. A and
E for each outcome will sum to 100%. The curved paths
show the correlations between the A and E factors for
each outcome.
Table 1. Descriptive statistics and twin pair intraclass correlations for fear conditioning risk estimates
Average risk estimatesa







mean (S.D.) MZ (95% CI) DZ (95% CI) t df p
Initial
development
6.05 (1.63) 3.70 (1.56) 2.35 (2.39) 0.14 (0.07–0.20) 0.08 (−0.01–0.17) 34.26 1936 <2.2 ×
10−16
Consolidation 7.67 (1.74) 2.28 (1.79) 5.39 (3.16) 0.24 (0.14–0.33) 0.12 (0.03–0.20) 70.53 1936 <2.2 ×
10−16
Extinction 5.06 (1.85) 3.11 (1.69) 1.95 (2.12) 0.18 (0.06–0.27) 0.04 (−0.05–0.13) 25.28 1936 <2.2 ×
10−16
Late extinction 1.96 (1.68) 1.6 (1.3) 0.36 (1.23) – – 6.01 1936 2.2 ×
10−9
This table compares amean and standard deviation (S.D.) for the average risk-estimate per stimulus (CS+ or CS−) during the first third of acquisition trials (initial development), last third of
acquisition trials (consolidation), first third of extinction trials (extinction) and the last third of extinction trials (late extinction), with bintraclass correlations (bootstrapped 95% CIs) between
the members of twin pairs for the caverage difference in risk-estimates between the CS+ and CS− for each experimental phase (initial development, consolidation and extinction).
MZ, monozygotic twins; DZ, dizygotic twins; CS+, the conditional stimulus paired with the aversive scream; CS−, the conditional stimulus that is never paired with the aversive scream; CS
differential, difference between CS+ and CS−.
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Estimates from this model are shown in Fig. 3. Initial develop-
ment, consolidation and extinction of fear were all significantly
influenced by additive genetic factors (A). For example, the esti-
mate of heritability (a2) for consolidation was 0.29 (0.18–0.39).
In addition, there were significant shared genetic effects (ra)
between all variables, with genetic correlations being highest
between initial development and consolidation of fear [rG = 0.99
(0.97–1.00)]. In comparison, genetic correlation were significantly
lower between each of the acquisition phases and extinction of
fear [initial development and extinction: rG = 0.42 (0.14–0.78);
consolidation and extinction: rG = 0.44 (0.05–0.75)]. The effect of
non-shared environment (E) was also significant for all variables
(range e2 = 0.71–0.83), with significant non-shared environmental
correlations (0.31–0.49) between all variables. See Table 2 for the
standardised proportion of the phenotypic variance between vari-
ables accounted for by A and E respectively.
Discussion
We present the largest twin study of fear conditioning to date,
providing evidence for genetic and non-shared environmental
influences. Discriminative fear learning is significantly heritable
during the initial development, consolidation and extinction of
fear conditioning. We demonstrated significant contributions
from non-shared environmental influences (which includes meas-
urement error), but no evidence for the contribution of common
environment. Shared genetic effects between initial development
and the consolidation of fear approached unity. This indicates
that the genetic variants involved in the initial development of
fear learning are virtually the same as those involved in the
later consolidation of fear learning. The genetic correlations
between both stages of fear acquisition and extinction were mod-
erate and significant, indicating either that some of the genetic
variants implicated in fear learning also play a role in the extinc-
tion of these learned associations. However, these genetic correla-
tions were around 0.5, indicating that roughly half the genetic
factors on extinction of fear are different from those on fear learn-
ing. Although a previous study provided preliminary evidence for
complete genetic overlap between acquisition and extinction of
fear, these results were difficult to interpret as CIs were not
included for estimates from the multivariate model (Hettema
et al., 2003). Our study provides further support for significant
shared genetic influences on acquisition and extinction. The
prior study also found that both acquisition and extinction of
fear were robustly heritable, with heritability estimates for fear
extinction substantially greater than we find (h2: 0.34–0.36).
This may be due to differences in our paradigm (in lab v. remotely
administered) and resultant measurement error, or due to differ-
ences in outcome variables (absolute v. differential expectancy rat-
ings). However, taken together, the results from present and prior
studies provide strong support for the role of genetic influences in
the acquisition and extinction of fear.
Findings should be considered in light of some limitations.
First, the remote delivery of the experiment necessitates lower
experimental control compared to laboratory delivery. This is par-
ticularly reflected in the number of individuals who removed their
headphones during the task, and thus excluded from analyses.
Second, the sample was drawn from a population-based twin
cohort. In future studies, it will be important to test whether
there are differences in the genetic and environmental contribu-
tors to fear conditioning between individuals with anxiety disor-
ders compared to healthy individuals.
Genetic influences on fear acquisition
We explored genetic influences on two stages of fear acquisition.
Initial fear development was calculated using risk-estimate differ-
ences for the CS+ and CS− during the first third of acquisition
trials. Fear consolidation was indexed by the risk-estimates differ-
ences during the final third of trials. Although initial development
and consolidation shared all of the same genetic influences, gen-
etic factors accounted for more variance in fear consolidation. A
persistent reduced capacity to distinguish between cues paired and
never paired with threat is similar to the tendency to interpret
neutral stimuli as threatening (negative interpretation bias). This
cognitive bias is a core feature of anxiety in adults and children
(Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, & van
IJzendoorn, 2007; Dudeney, Sharpe, & Hunt, 2015; Lau &
Waters, 2017; Lester, Lisk, Carr, Patrick, & Eley, 2019).
Generalised anxiety disorder (GAD), in particular, is associated
with interpretation biases (Eysenck, MacLeod, & Mathews,
1987; Eysenck, Mogg, May, Richards, & Mathews, 1991; Hayes,
Hirsch, Krebs, & Mathews, 2010; Mathews, Richards, &
Eysenck, 1989; Mogg et al., 1994), which we have previously
shown to be heritable (Brown et al., 2014; Eley et al., 2008; Lau,
Belli, Gregory, & Eley, 2014). In sum, the consolidation of fear
learning is probably more relevant than initial fear learning to
understanding anxiety disorders. Notably, the heritability of fear
consolidation (29%) is similar to estimates of GAD from previous
twin studies (Hettema, Neale, & Kendler, 2001). This supports the
possibility that the consolidation of fear conditioning is a relevant
mechanism underlying disordered anxiety.
Genetic and environmental influences on fear extinction
The modest but significant heritability of fear extinction (15%)
suggests that a relatively small degree of variation in fear extinc-
tion in healthy individuals is influenced by genetic factors. The
only prior twin study of fear conditioning to date (Hettema
et al., 2003) estimated the heritability of fear extinction of the
CS+ specifically to be 36% (95% CI 18–52), and the CS− 34%
(95% CI 16–50). The CIs for the current study include estimates
up to 25% (95% CI 4–25). It is possible that the range of overlap
between CIs from the prior and current study (16–25) may
represent the ‘true’ range of heritability. There have been no
twin studies of treatment response for anxiety, and two genome-
wide meta analyses of CBT treatment response have failed to
derive significant heritability estimates despite having statistical
power to detect heritability of 30% or greater (Coleman et al.,
2016; Rayner et al., 2019). This study thus adds to our limited
knowledge about the relative role for genes and the environment
in fear extinction, a mechanism underpinning exposure-based
treatment, a core component of CBT for anxiety disorders.
The high estimate of the non-shared environment (e2 = 85%)
influencing fear extinction in this study partially reflects high
measurement error given our task (Purves et al., 2019).
Furthermore, the use of difference scores as an outcome, which,
while reducing the total number of variables examined, aggregates
the error variance of each individual stimuli, and thus inflates the
overall non-shared environmental estimate.
There are several plausible contributors to variable treatment
response over and above direct genetic influences. These include
specific life experiences, and individual characteristics such as
unemployment, low educational attainment and poor interper-
sonal relationships that are also known to reduce treatment
6 K. L. Purves et al.
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efficacy (DeRubeis et al., 2014; Mojtabai, 2017; Newman, Llera,
Erickson, Przeworski, & Castonguay, 2013; Renaud, Russell, &
Myhr, 2014). Specific disorder profiles, including greater symp-
tom severity, comorbidity with other mental health disorders
and poor treatment adherence are associated with poor treatment
response in anxious adults and children (Hudson et al., 2013, 2015;
Rayner et al., 2019; Wergeland et al., 2016). Understanding modifi-
able personal risk factors may help identify areas for intervention
that could serve as a precursor or adjunct to therapy to further
enhance the effect of exposure within a personalised medicine
framework.
Genetic and environmental overlap between fear acquisition
and extinction
There were moderate genetic (ra = 0.41–0.44) and non-shared
environment (re = 0.31–0.41) correlations between fear acquisi-
tion and extinction. If fear extinction is considered a credible
marker underlying treatment response (Craske, Hermans, &
Vervliet, 2018), then at least some of the genetic markers under-
lying treatment response are the same as those underlying anxiety
development, and approximately half the genes relevant to extinc-
tion should be identified in GWAS of anxiety. This ‘cause informs
cure’ (Uher, 2008) perspective would mean that findings from the
rapidly growing anxiety genetics field would be relevant to under-
standing genetic influences on psychological treatment response.
We note genetic correlations between fear acquisition and
extinction were below 0.5, indicating that distinct influences
exist. Crucially, this indicates understanding the genetics of anx-
iety disorder is not sufficient to fully understand the genetics of
psychological treatment response. It continues to be important
to find ways of investigating treatment response as a distinct
phenotype in large samples of individuals with sufficient depth
of phenotyping to explore the role of variance in a range of envir-
onmental and individual factors within genetically informed
designs.
Conclusions
We presented robust evidence for genetic influences on fear
acquisition and extinction, shedding light on possible mechan-
isms underlying known genetic influences on anxiety. We have
also shown moderate genetic overlap between fear acquisition
and extinction. This indicates that genetic susceptibility to devel-
oping fears is likely to have a moderate influence on reducing
learned fears, for example through exposure-based treatment.
Future studies using genotyped samples with fear conditioning
or treatment outcome data will enable more detailed investigation
of the genetics of the development and treatment of anxiety.
In conclusion, these findings represent a significant advance in
the genetics of fear acquisition and extinction, two key processes
underlying the development and exposure-based treatment of
anxiety disorders.
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